Location | 1998-2008 | |||||||
---|---|---|---|---|---|---|---|---|
1-year survival | 5-year survival | |||||||
Overall | Male | Female | Pvaluea | Overall | Male | Female | Pvaluea | |
All sites | 88.0% | 86.0% | 90.6% | <.0001 | 66.5% | 60.3% | 74.2% | <.0001 |
Stomach | 90.1% | 87.7% | 92.8% | <.0001 | 69.4% | 62.1% | 77.5% | <.0001 |
Small intestine | 88.1% | 86.5% | 90.3% | 0.0009 | 65.1% | 60.7% | 71.3% | 0.0008 |
Colon/rectum | 87.7% | 89.5% | 85.6% | 0.1666 | 72.4% | 66.6% | 78.7% | 0.0732 |
Esophagus/othersb | 71.3% | 66.4% | 77.8% | 0.1321 | 43.4% | 36.8% | 51.9% | 0.0897 |
1998-2001 | ||||||||
All sites | 81.8% | 78.5% | 86.4% | <.0001 | 58.9% | 52.7% | 67.4% | <.0001 |
Stomach | 85.1% | 80.4% | 90.9% | 0.0010 | 61.4% | 53.3% | 71.3% | 0.0006 |
Small intestine | 77.6% | 75.5% | 80.9% | 0.0336 | 55.3% | 52.5% | 59.6% | 0.0368 |
Colon/rectum | 80% | 80% | 80% | 0.1118 | 60% | 50% | 75% | 0.0519 |
Esophagus/othersb | 60% | 75% | -- | -- | 40% | 50% | -- | -- |
2002-2004 | ||||||||
All sites | 90.0% | 87.5% | 92.9% | <.0001 | 67.0% | 59.7% | 76.0% | <.0001 |
Stomach | 91.0% | 88.5% | 93.9% | <.0001 | 70.2% | 61.3% | 80.1% | <.0001 |
Small intestine | 90.4% | 89.3% | 92.0% | 0.4008 | 64.9% | 59.9% | 72.0% | 0.2272 |
Colon/rectum | 94.5% | 94.9% | 94.1% | 0.4290 | 80.8% | 74.4% | 88.2% | 0.3414 |
Esophagus/othersb | 74.1% | 61.3% | 88.9% | 0.0947 | 37.9% | 29.0% | 48.2% | 0.1277 |
2005-2008 | ||||||||
All sites | 89.7% | 88.6% | 90.9% | <.0001 | 70.2% | 65.5% | 75.8% | <.0001 |
Stomach | 92.0% | 90.9% | 93.1% | 0.0006 | 73.2% | 68.9% | 77.8% | 0.0004 |
Small intestine | 91.6% | 90.3% | 93.4% | 0.0081 | 70.5% | 65.9% | 76.9% | 0.0103 |
Colon/rectum | 86.4% | 91.1% | 81.4% | 0.8154 | 74.1% | 75.3% | 73.0% | 0.9534 |
Esophagus/othersb | 70.4% | 68.1% | 73.6% | 0.1976 | 46.9% | 37.7% | 58.7% | 0.1796 |